EBV is necessary for proliferation of dually infected primary effusion lymphoma cells

Cancer Research

Volumn 68, Issue 17, 2008, Pages 6963-6968

  Mack, Amanda A ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; DNA BINDING; EPSTEIN BARR VIRUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; CELL LINE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

CELL LINE; CELL PROLIFERATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, PRIMARY EFFUSION;

EID: 52049118069     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0627     Document Type: Article

References (15)

1. Jenner RG, Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 2002;1602:1-22.
2. Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990;94:170-5.
3. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989;73:792-9.
4. Green I, Espiritu E, Ladanyi M, et al. Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Mod Pathol 1995;8:39-45.
5. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
6. Lee DY, Sugden B. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene 2008;27:2833-42.
7. Nanbo A, Sugden A, Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 2007;26:4252-62.
8. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996;93:14862-7.
9. Kennedy G, Komano J, Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A 2003;100:14269-74.
10. Sternas L, Middleton T, Sugden B. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol 1990;64:2407-10.
11. Krithivas A, Young DB, Liao G, Greene D, Hayward SD. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 2000;74:9637-45.
12. Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 2005;105:2510-8.
13. Weis E, Yasuko M, Hahn A, et al. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 2008;111:320-7.
14. Trivedi P, Takazawa K, Zompetta C. Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr Virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. Blood 2004;103:313-6.
15. Lindner SE, Sugden B. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 2007;58:1-12.